Literature DB >> 9126143

Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease.

J D Elsworth1, R H Roth.   

Abstract

This article gives a brief overview of the current understanding of the life cycle of the dopamine molecule, covering dopamine synthesis, storage, release, receptor and autoreceptor interactions, and reuptake. Special consideration is given to biochemical changes that occur in the nigrostriatal dopamine system in Parkinson's disease and how gene therapy may provide a new strategy for reversing parkinsonian biochemical deficits.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126143     DOI: 10.1006/exnr.1996.6379

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  57 in total

1.  Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite.

Authors:  Lydia M Mexas; Virginia R Florang; Jonathan A Doorn
Journal:  Neurotoxicology       Date:  2011-04-14       Impact factor: 4.294

2.  A pressurized nitrogen counterbalance to cortical glutamatergic pathway stimulation.

Authors:  Nicolas Vallee; Jean-Claude Rostain; Jean-Jacques Risso
Journal:  Neurochem Res       Date:  2010-01-29       Impact factor: 3.996

Review 3.  Catecholaminergic based therapies for functional recovery after TBI.

Authors:  Nicole D Osier; C Edward Dixon
Journal:  Brain Res       Date:  2015-12-19       Impact factor: 3.252

Review 4.  A review of the effects of FSCV and microdialysis measurements on dopamine release in the surrounding tissue.

Authors:  Andrea Jaquins-Gerstl; Adrian C Michael
Journal:  Analyst       Date:  2015-06-07       Impact factor: 4.616

5.  Pre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primates.

Authors:  Xiomara A Perez; Neeraja Parameswaran; Luping Z Huang; Kathryn T O'Leary; Maryka Quik
Journal:  J Neurochem       Date:  2008-02-01       Impact factor: 5.372

6.  Catechol and aldehyde moieties of 3,4-dihydroxyphenylacetaldehyde contribute to tyrosine hydroxylase inhibition and neurotoxicity.

Authors:  Lydia M M Vermeer; Virginia R Florang; Jonathan A Doorn
Journal:  Brain Res       Date:  2012-07-31       Impact factor: 3.252

7.  Differential effects of central injections of D1 and D2 receptor agonists and antagonists on male sexual behavior in Japanese quail.

Authors:  H K Kleitz-Nelson; C A Cornil; J Balthazart; G F Ball
Journal:  Eur J Neurosci       Date:  2010-06-26       Impact factor: 3.386

8.  Pramipexole modulates the neural network of reward anticipation.

Authors:  Zheng Ye; Anke Hammer; Estela Camara; Thomas F Münte
Journal:  Hum Brain Mapp       Date:  2011-05       Impact factor: 5.038

9.  Controlled iontophoresis coupled with fast-scan cyclic voltammetry/electrophysiology in awake, freely moving animals.

Authors:  Anna M Belle; Catarina Owesson-White; Natalie R Herr; Regina M Carelli; R Mark Wightman
Journal:  ACS Chem Neurosci       Date:  2013-03-26       Impact factor: 4.418

10.  Alterations in the nigrostriatal dopamine system after acute systemic PhIP exposure.

Authors:  Zeynep Sena Agim; Jason R Cannon
Journal:  Toxicol Lett       Date:  2018-01-31       Impact factor: 4.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.